In lethally irradiated normal mice reconstituted with both normal and autoimmune mutant viable motheaten (me') bone marrow, the me'-derived B and T cells display aberrant behavior, while those derived from the normal bone marrow develop and function normally. The observed developmental abnormalities of me' B and T lymphocytes are therefore intrinsic to these cell types, rather than being determined by defective influences from the cells' environment. These data bring into question the in vivo significance of reported intercellular regulatory defects in motheaten (me) and me' mice and suggest that these mutations affect a gene whose product acts cell autonomously in the development of several hematopoietic cell lineages including B and T lymphocytes.
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Mice homozygous for either ofthe allelic autosomal recessive mutations motheaten (me) (1) or viable motheaten (mev) (2) show the most severe genetically determined immunological disorders known. Such mice develop high levels ofpolyclonal and autoreactive immunoglobulin (3, 4) , lack IgD-positive B cells (4, 5) , are severely deficient in both humoral and cellular immunity (3, 6) , and die at average ages of 3 and 9 weeks (1, 2), respectively. Other abnormalities reported in these mice include an extreme overrepresentation of the B-cell population bearing the Ly-1 surface antigen (4), high circulating levels of two B-cell maturation-promoting lymphokines (7, 8) , early thymic atrophy (2) , reduced prothymocyte migration (9) , and defective stromal cell function (10, 11) . These findings suggest the possibility that the aberrant lymphocyte behavior in me and mev mice may be due to abnormal environmental (i.e., extracellular) influences acting on many cell types. To evaluate this hypothesis, we produced chimeras by injecting either normal, mev, or equal mixtures of both types of bone marrow into lethally irradiated normal recipients and then observed the development ofthe lymphoid cells arising from each type of marrow.
METHODS
Mice. The following mice were used in these studies: C57BL/6J, B6.C-Igha, B6.PL-Thy-la, and B6.CAST-Gpi-la. Double congenics were selected and propagated from among the F2 intercross progeny generated from the parental stocks shown above. Recipient normal mice were given 1000 R (1 R = 0.258 mC/kg) of whole body irradiation from a 137Cs source and were then injected intravenously with 3 x 106 of the indicated types of bone marrow cells. (Mice given two types of bone marrow received 6 x 106 total cells.) Donor and recipient mice of both sexes were 1-2 months old at the time of irradiation and bone marrow transfer.
ELISAs. IgM levels were determined by sandwich ELISAs (4 Enzyme Assays. Heparinized blood was collected from the retroorbital sinus, centrifuged in a hematocrit tube, and erythrocytes from below the buffy coat layer were collected, frozen, and lysed into H20. Gpi-1 gels were prepared as described (18) .
RESULTS
To separately follow the development of B and T lymphocytes from normal and mev bone marrow, C57BL/6J (B6)-background congenic mouse stocks differing in their me, immunoglobulin heavy chain (Igh) (on B cells), Thy-l (on T cells), and glucose phosphate isomerase-1 (Gpi-J) alleles (in all cell types) were constructed and used. Products of different Igh alleles were distinguished through the use of monoclonal antibodies specific for Igh constant regions ,la, ,b, 3a, and 8b. Monoclonal antibodies specific for Thy-la and Thy-lb were also used, while Gpi-1 was typed by cellulose acetate electrophoresis. Since from three sources (its own plus those from the two donors), the following six groups of chimeras were produced to unambiguously observe the descendants of either the normal (me') or the mev donor bone marrow compartment in both single and mixed chimeras: I, me+,1ghb,Thy-Ja,Gpi-Ja (donor) -* me+,Ighb,Thy-Ja,Gpi-Ja (recipient); II, me', Igha, Thy Jb,Gpilb -* me+,Ighb, Thy-la,Gi la; III, me+,Ighb Thy-JaGpi-Ja plus mevIghaThy-lGpi-lb me+,Ighb,Thy-Ja,Gpi-Ja; IV, me+,Igha,Thy-la -* me+, IghbThy-lb; V, mev,Ighb,Thy~Jb -l me+,Ighb,Thy-Jb; VI, me+,Igha, Thy-la plus mev,Ighb, Thy-l b me+,Ighb, Thy_ Ib.
Note that all recipients were normal (non-motheaten, indicated as me+) mice. The mixed chimeras of group III were those in which mev-derived cells and immunoglobulin could be clearly distinguished by their Igh, Thy-i, and Gpi-J alleles from those from the normal competitor and recipient, while groups I and II were the necessary single donor controls for group III. Similarly, group VI allowed unequivocal determination of the fate of normal donor marrow, identified by Igh and Thy-i, distinct from the competing mev marrow and the normal recipient (groups IV and V being the associated single donor controls for group VI). As controls for the monoclonal antibody and enzyme determinations, unmanipulated Igh' (group VII) and Thy-Ja,Gpi-Ja (group VIII) mice were typed in each assay. A kinetic analysis (Fig. 1) indicated that chimeras receiving only mev, or mixed normal and mev, bone marrow showed elevated serum IgM levels (measured by ELISA) compared to mice given only normal bone marrow starting 2 weeks after reconstitution, peaking at 4 weeks, and essentially constant thereafter. The inclusion of normal bone marrow did not measurably affect the excess IgM secretion caused by mev bone marrow, although it did significantly increase the recipients' survival time from -2 to -4 months (data not shown).
Total, ,a-, and ,ub-containing serum IgM levels were quantitated by ELISA during the period of stable excess IgM production-i.e., from 1-2 months after transfer (Fig. 2) . Comparison of the mev-derived IgMa levels (Fig. 2B , asterisks) between groups II and III indicates that the excessive IgM production by mev B cells was not reduced by inclusion of normal marrow in the cells transferred. Similarly, the normal-derived IgMa levels in groups IV and VI (triangles) show that non-mev B cells secreted IgM normally despite the presence of mev bone marrow-derived cells. Excess IgM was therefore secreted by donor mev B cells in all cases in which they were present but did not include any measurable contribution by the normal donor or recipient cell populations. Also worthy ofnote is the fact that normal levels of IgM (-0.1 mg/ml) in mev normal (group II) and normal -+ normal (group IV) were host-derived (Fig. 2C, IgMb) , showing that the host B-cell compartment in bone marrow recipients can be functional but can be distinguished by the genetic marker experimental design used here. Two-color immunofluorescent staining and a fluorescenceactivated cell sorter were used to analyze the origin of the cell populations in these bone marrow chimeras. Despite procedures designed to eliminate cytophilic immunoglobulin or specifically bound autoantibodies, double labeling of ga and Ab allotypes on the surface of many cells was observed (data not shown), possibly due to secreted IgM reactivity toward cell-surface antigens (19) or network idiotypes on surface immunoglobulin itself (20) . The identity and origin of cells in these chimeras were thus difficult to determine unequivocally Chimera Groups (Fig. 3) , measured 1-2 months after cell transfer. Comparison of groups II and III shows that the profound lack of IgDa-and Thy-lb-bearing cells derived from mev bone marrow (asterisks) was not affected by the inclusion of normal bone marrow. Similarly, groups IV and VI indicate that the generation of IgDa-and Thy-la-bearing B and T cells from normal marrow (triangles) was not affected by the presence of mev-derived cells and disease. Again with general relevance to bone marrow transfer studies, appreciable levels of host-derived B and T cells (10-70%o) were detected in mev -* normal (group II: host is IgDb, Thy-Ja) and normal -* normal (group IV: host is IgDb, Thy-lb) chimeras. Patterns similar to those presented for lymph node were also observed in spleen and thymus (data not shown). However, all animals given mev bone marrow, whether alone or together with normal marrow, contained significantly fewer splenic B and T lymphocytes, probably due to the overproduction of granulocytes, monocytes, and erythrocytes seen in these spleens (data not shown). In agreement with a previous report (21) , mev-derived thymocytes showed an even greater increase than lymph node T cells in mixed as compared to mev-only chimeras, but these mev-derived T cells were not found in the lymph nodes at levels equivalent to the normal-derived T cells in the same mixed chimeras (group III).
One possible explanation for the lack of mev-derived B and T cells in the mixed chimeras might be a competitive defect of mev as compared to normal stem cells. To evaluate this possibility, the presence of mev hemopoietic stem cells was evaluated by examining Gpi-1 levels in another stem cellderived compartment, circulating erythrocytes. Fig. 4 shows that group III mixed chimera erythrocytes contained equal Gpi-1 allotypic forms (2 months after cell transfer), indicating that mev and normal stem cells were equivalently present and producing erythrocytes in the mixed chimeras. Similar Gpi-1 patterns could be demonstrated by 3 weeks after cell transfer (data not shown). 
DISCUSSION
The inescapable conclusion from these studies is that the major developmental anomalies of both mev B and T lymphocytes are intrinsic to these cells, rather than primarily determined by defective influences from the cells' environment. Conversely, the simultaneous presence of mev cells and disease process has little or no influence on normal B and T cells developing in the same environment. Together, these findings show that previously reported possible intercellular peculiarities of mev lymphocytes [defects in regulatory Ly-1 B cells (4), lymphokines (7, 8) , and stromal cells (10, 11) ] are not sufficient to explain the in vivo behavior of mev B and T cells, although such defects might still play a role if mev cells respond differently than normal cells to such aberrant influences.
The me and mev mutations thus appear to identify a gene whose intracellular (i.e., cell autonomous) expression is critical to the proper development and function ofboth B and T lymphocytes. In fact, this gene may be important in other hematopoietic cell lineages besides lymphocytes, since mev erythrocytes display characteristic morphological malformations (2), and me macrophages are hyperproliferative in vitro (22) . Mutations in multilineage-active genes, such as me and mev (described here) or "severe combined immunodeficiency," which affects B-and T-lymphocyte development (23) possibly through a common receptor recombinase system (24) , may in general lead to more severe immunological abnormalities than mutations primarily affecting a single cell Groups I-VI were the same animals as those in Fig. 2 , while groups VII and VIII were included as controls for the specificity of the antibodies used. lineage that then indirectly affect others. Examples of this latter situation include the "nude" mutation (25, 26) , which drastically reduces T-cell function by interfering with normal thymus differentiation, and the mutations "lymphoproliferation" and "generalized lymphoproliferative disease," whose humoral autoimmunity is completely dependent on the function of mature postthymic T cells (refs. 27-29; unpublished data). Ongoing molecular mapping and cloning studies of the me and mev mutations should therefore ultimately reveal a gene intimately involved in the development of both B and T lymphocytes, whose mutations lead to severe developmental aberrations, immunodeficiency, and autoimmunity.
